Niels Rahe-Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Niels Rahe-Meyer has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Michael Winterhalter
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
10 shared publications S. Piepenbrock
Department of Anaesthesiology
10 shared publicationsC. Solomon
Department of Anaesthesiology and Intensive Care Medicine, SALK University Hospital, Salzburg, Austria; and †Clinic for Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover; ‡Cardiac Surgery Clinic, University Clinic Grosshadern, Munich; §Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover; and ∥Department of Anesthesiology and Intensive Care Medicine, Franzikus Hospital, Bielefeld, Germany
5 shared publicationsJ. Zuk
Department of Anesthesiology
5 shared publications- Christian Weilbach
Anaesthesiology, St-Josefs-Hospital, Krankenhausstraße 13, D-49661 Cloppenburg, Germany
4 shared publications C. Gras
Department of Anesthesiology
3 shared publications
Latest Publications
- Open Access
- 1 April 2014
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 58 (2) , 63-64
Time Course of Haemostatic Effects of Fibrinogen Concentrate Administration in Aortic Surgery
- 1 April 2014
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 58 (2) , 63-64
Open AccessTime Course of Haemostatic Effects of Fibrinogen Concentrate Administration in Aortic Surgery
- Open Access
- 1 May 2013
- Published by Springer Nature in Retrovirology
- Vol. 10 (1) , 48
Platelet activation suppresses HIV-1 infection of T cells
Background: Platelets, anucleate cell fragments abundant in human blood, can capture HIV-1 and platelet counts have been associated with viral load and disease progression. However, the impact of platelets on HIV-1 infection of T cells is unclear. Results: We found that platelets suppress HIV-1 spread in co-cultured T cells in a concentration-dependent manner. Platelets containing granules inhibited HIV-1 spread in T cells more efficiently than degranulated platelets, indicating that the granule content might exert antiviral activity. Indeed, supernatants from activated and thus degranulated platelets suppressed HIV-1 infection. Infection was inhibited at the stage of host cell entry and inhibition was independent of the viral strain or coreceptor tropism. In contrast, blockade of HIV-2 and SIV entry was less efficient. The chemokine CXCL4, a major component of platelet granules, blocked HIV-1 entry and neutralization of CXCL4 in platelet supernatants largely abrogated their anti-HIV-1 activity. Conclusions: Release of CXCL4 by activated platelets inhibits HIV-1 infection of adjacent T cells at the stage of virus entry. The inhibitory activity of platelet-derived CXCL4 suggests a role of platelets in the defense against infection by HIV-1 and potentially other pathogens.
- 1 May 2013
- Published by Springer Nature in Retrovirology
- Vol. 10 (1) , 48
Open AccessPlatelet activation suppresses HIV-1 infection of T cells
Background: Platelets, anucleate cell fragments abundant in human blood, can capture HIV-1 and platelet counts have been associated with viral load and disease progression. However, the impact of platelets on HIV-1 infection of T cells is unclear. Results: We found that platelets suppress HIV-1 spread in co-cultured T cells in a concentration-dependent manner. Platelets containing granules inhibited HIV-1 spread in T cells more efficiently than degranulated platelets, indicating that the granule content might exert antiviral activity. Indeed, supernatants from activated and thus degranulated platelets suppressed HIV-1 infection. Infection was inhibited at the stage of host cell entry and inhibition was independent of the viral strain or coreceptor tropism. In contrast, blockade of HIV-2 and SIV entry was less efficient. The chemokine CXCL4, a major component of platelet granules, blocked HIV-1 entry and neutralization of CXCL4 in platelet supernatants largely abrogated their anti-HIV-1 activity. Conclusions: Release of CXCL4 by activated platelets inhibits HIV-1 infection of adjacent T cells at the stage of virus entry. The inhibitory activity of platelet-derived CXCL4 suggests a role of platelets in the defense against infection by HIV-1 and potentially other pathogens.
- 31 December 2011
- Published by Elsevier in Thrombosis Research
- Vol. 128, S17-S19
Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery
- 31 December 2011
- Published by Elsevier in Thrombosis Research
- Vol. 128, S17-S19
Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery
- 1 January 2011
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 9 (1) , 1-5
Fibrinogen concentrate for management of bleeding
- 1 January 2011
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 9 (1) , 1-5
Fibrinogen concentrate for management of bleeding
- 12 June 2010
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 27, 105
Effect of cardio-pulmonary bypass on procoagulant components of haemostasis in cardiac surgery
- 12 June 2010
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 27, 105
Effect of cardio-pulmonary bypass on procoagulant components of haemostasis in cardiac surgery
- 1 September 2009
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 138 (3) , 694-702
Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery
- 1 September 2009
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 138 (3) , 694-702
Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery
- Open Access
- 1 June 2009
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 102 (6) , 785-792
Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study
Bleeding diathesis after aortic valve operation and ascending aorta replacement (AV-AA) is managed with fresh-frozen plasma (FFP) and platelet concentrates. The aim was to compare haemostatic effects of conventional transfusion management and FIBTEM (thromboelastometry test)-guided fibrinogen concentrate administration. A blood products transfusion algorithm was developed using retrospective data from 42 elective patients (Group A). Two units of platelet concentrate were transfused after cardiopulmonary bypass, followed by 4 u of FFP if bleeding persisted, if platelet count was < or =100 x 10(3) microl(-1) when removing the aortic clamp, and vice versa if platelet count was >100 x 10(3) microl(-1). The trigger for each therapy step was > or =60 g blood absorbed from the mediastinal wound area by dry swabs in 5 min. Assignment to two prospective groups was neither randomized nor blinded; Group B (n=5) was treated according to the algorithm, Group C (n=10) received fibrinogen concentrate (Haemocomplettan P/Riastap, CSL Behring, Marburg, Germany) before the algorithm-based therapy. A mean of 5.7 (0.7) g fibrinogen concentrate decreased blood loss to below the transfusion trigger level in all Group C patients. Group C had reduced transfusion [mean 0.7 (range 0-4) u vs 8.5 (5.3) in Group A and 8.2 (2.3) in Group B] and reduced postoperative bleeding [366 (199) ml vs 793 (560) in Group A and 716 (219) in Group B]. In this pilot study, FIBTEM-guided fibrinogen concentrate administration was associated with reduced transfusion requirements and 24 h postoperative bleeding in patients undergoing AV-AA.
- 1 June 2009
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 102 (6) , 785-792
Open AccessBleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study
Bleeding diathesis after aortic valve operation and ascending aorta replacement (AV-AA) is managed with fresh-frozen plasma (FFP) and platelet concentrates. The aim was to compare haemostatic effects of conventional transfusion management and FIBTEM (thromboelastometry test)-guided fibrinogen concentrate administration. A blood products transfusion algorithm was developed using retrospective data from 42 elective patients (Group A). Two units of platelet concentrate were transfused after cardiopulmonary bypass, followed by 4 u of FFP if bleeding persisted, if platelet count was < or =100 x 10(3) microl(-1) when removing the aortic clamp, and vice versa if platelet count was >100 x 10(3) microl(-1). The trigger for each therapy step was > or =60 g blood absorbed from the mediastinal wound area by dry swabs in 5 min. Assignment to two prospective groups was neither randomized nor blinded; Group B (n=5) was treated according to the algorithm, Group C (n=10) received fibrinogen concentrate (Haemocomplettan P/Riastap, CSL Behring, Marburg, Germany) before the algorithm-based therapy. A mean of 5.7 (0.7) g fibrinogen concentrate decreased blood loss to below the transfusion trigger level in all Group C patients. Group C had reduced transfusion [mean 0.7 (range 0-4) u vs 8.5 (5.3) in Group A and 8.2 (2.3) in Group B] and reduced postoperative bleeding [366 (199) ml vs 793 (560) in Group A and 716 (219) in Group B]. In this pilot study, FIBTEM-guided fibrinogen concentrate administration was associated with reduced transfusion requirements and 24 h postoperative bleeding in patients undergoing AV-AA.
- 1 May 2009
- Published by Wiley in Anaesthesia
- Vol. 64 (6) , 666-673
Comparison of breathing tube connectors during invasive bronchial procedures*
Summary: Bronchoscopy and bronchial suctioning during intra‐operative artificial ventilation often causes leakage from the ventilation circuit with a decrease in ventilatory parameters and possible workplace contamination with anaesthetic gases. Different connectors have been developed to reduce gas leakage. We evaluated the following connectors : VBM 2 mm, 3 mm and 5 mm, Bodai Suction‐Safe, Bodai Bronch‐Safe and Bodai Trach‐Safe, as well as the BE 105‐7, BE 105‐8 and SH 7‐45. Invasive bronchial instruments (catheters, bronchoscopes and bronchial blockers) with 1.67–7.33 mm diameter were used. Pressure‐controlled ventilation was performed on a test lung using a ventilator. Sevoflurane concentration in the room was measured 0.2 and 1.5 m from the connector using a photo‐acoustic infrared‐spectroscope. The VBM connectors caused the least gas leak and ensured stability of ventilation parameters even at peak pressures when combined with smaller instruments. With instruments > 6 mm, BE 105‐7, BE 105‐8 and SH 7‐45 connectors performed best. The Bodai connectors showed a reduced ability to prevent leakage and to keep ventilatory parameters stable. All connectors, excluding the Bodai Trach‐Safe, prevented exposure to anaesthetic gases beyond the current safety recommendations when combined with the fitting instruments. The connectors showed different ranges of tightness, equivalent to different ranges of compatibility with the instruments used.
- 1 May 2009
- Published by Wiley in Anaesthesia
- Vol. 64 (6) , 666-673
Comparison of breathing tube connectors during invasive bronchial procedures*
Summary: Bronchoscopy and bronchial suctioning during intra‐operative artificial ventilation often causes leakage from the ventilation circuit with a decrease in ventilatory parameters and possible workplace contamination with anaesthetic gases. Different connectors have been developed to reduce gas leakage. We evaluated the following connectors : VBM 2 mm, 3 mm and 5 mm, Bodai Suction‐Safe, Bodai Bronch‐Safe and Bodai Trach‐Safe, as well as the BE 105‐7, BE 105‐8 and SH 7‐45. Invasive bronchial instruments (catheters, bronchoscopes and bronchial blockers) with 1.67–7.33 mm diameter were used. Pressure‐controlled ventilation was performed on a test lung using a ventilator. Sevoflurane concentration in the room was measured 0.2 and 1.5 m from the connector using a photo‐acoustic infrared‐spectroscope. The VBM connectors caused the least gas leak and ensured stability of ventilation parameters even at peak pressures when combined with smaller instruments. With instruments > 6 mm, BE 105‐7, BE 105‐8 and SH 7‐45 connectors performed best. The Bodai connectors showed a reduced ability to prevent leakage and to keep ventilatory parameters stable. All connectors, excluding the Bodai Trach‐Safe, prevented exposure to anaesthetic gases beyond the current safety recommendations when combined with the fitting instruments. The connectors showed different ranges of tightness, equivalent to different ranges of compatibility with the instruments used.
- 19 January 2009
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 53 (2) , 168-175
Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry
Background: Platelet dysfunction contributes to the pathophysiology of bleeding complications during and after cardiac surgery. In most surgical institutions, no peri‐operative point‐of‐care monitoring of platelet function is used. We evaluated the usefulness of the Multiplate® platelet function analyser based on impedance aggregometry for identifying groups of patients at a high risk of transfusion of platelet concentrates (PC).Methods: Platelet function parameters were determined in 60 patients before and after routine cardiac surgery. Impedance aggregometry measurements were performed on Multiplate® using ADP (ADPtest), collagen (COLtest) and thrombin receptor activating peptide (TRAPtest) as platelet activators. The correlations between the aggregometry results and the transfusion of PC were calculated. The results of the aggregation tests were also divided into tertiles and the differences in PC transfusion between the low and the high tertile were assessed.Results: Low aggregometry delimited groups of patients with significantly higher PC transfusion. In the receiver operating characteristic curve, low pre‐operative aggregation in the ADPtest identified patients with high total transfusion of PC (area under the curve 0.74, P=0.001), while the ADPtest performed at the end of the operation identified patients with high PC transfusion on the intensive care unit (ICU) (area under the curve 0.76, P=0.002).Conclusions: Near‐patient platelet aggregation may allow the identification of patients with enhanced risk of PC transfusion, both pre‐operatively and upon arrival on the ICU.
- 19 January 2009
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 53 (2) , 168-175
Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry
Background: Platelet dysfunction contributes to the pathophysiology of bleeding complications during and after cardiac surgery. In most surgical institutions, no peri‐operative point‐of‐care monitoring of platelet function is used. We evaluated the usefulness of the Multiplate® platelet function analyser based on impedance aggregometry for identifying groups of patients at a high risk of transfusion of platelet concentrates (PC).Methods: Platelet function parameters were determined in 60 patients before and after routine cardiac surgery. Impedance aggregometry measurements were performed on Multiplate® using ADP (ADPtest), collagen (COLtest) and thrombin receptor activating peptide (TRAPtest) as platelet activators. The correlations between the aggregometry results and the transfusion of PC were calculated. The results of the aggregation tests were also divided into tertiles and the differences in PC transfusion between the low and the high tertile were assessed.Results: Low aggregometry delimited groups of patients with significantly higher PC transfusion. In the receiver operating characteristic curve, low pre‐operative aggregation in the ADPtest identified patients with high total transfusion of PC (area under the curve 0.74, P=0.001), while the ADPtest performed at the end of the operation identified patients with high PC transfusion on the intensive care unit (ICU) (area under the curve 0.76, P=0.002).Conclusions: Near‐patient platelet aggregation may allow the identification of patients with enhanced risk of PC transfusion, both pre‐operatively and upon arrival on the ICU.
- 1 December 2008
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 107 (6) , 1791-1797
An Evaluation of Cyclooxygenase-1 Inhibition Before Coronary Artery Surgery: Aggregometry Versus Patient Self-Reporting
Platelet dysfunction due to antiplatelet therapy contributes to perioperative bleeding. Several trials investigating the influence of aspirin intake within the 5 days before surgery reported that transfusion requirements were either increased or not significantly affected by aspirin intake. Our objective was to compare the assessment of aspirin intake by patient self-reporting and by measurement of platelet function with regard to transfusion requirements. In a prospective trial, a standardized questionnaire was used in 100 patients for aspirin intake within the 5 days immediately before coronary artery bypass grafting. Whole blood platelet aggregation triggered by arachidonic acid was investigated using the Multiplate platelet function analyzer. Eleven of 23 patients with aspirin intake within the 5 days before the intervention showed an abnormal aggregation response. Nine of 77 patients who reported no aspirin intake before surgery had an abnormal aggregation response. There were no significant differences in chest tube drainage and red blood cell transfusion over the first 24 h postoperatively between patients with and without reported aspirin intake. There was no significant difference in chest tube drainage over the first 24 h postoperatively between patients showing normal or abnormal aggregation response. Patients with abnormal aggregation before intervention (<51 U) received significantly more platelet transfusion than patients with normal aggregation (1.1 U compared to 0.3 U, P = 0.001). Our results suggest that arachidonic acid-induced aggregation in whole blood may be a better predictor of platelet-related coagulopathy and platelet transfusion than the assessment of aspirin intake by patient self-reporting.
- 1 December 2008
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 107 (6) , 1791-1797
An Evaluation of Cyclooxygenase-1 Inhibition Before Coronary Artery Surgery: Aggregometry Versus Patient Self-Reporting
Platelet dysfunction due to antiplatelet therapy contributes to perioperative bleeding. Several trials investigating the influence of aspirin intake within the 5 days before surgery reported that transfusion requirements were either increased or not significantly affected by aspirin intake. Our objective was to compare the assessment of aspirin intake by patient self-reporting and by measurement of platelet function with regard to transfusion requirements. In a prospective trial, a standardized questionnaire was used in 100 patients for aspirin intake within the 5 days immediately before coronary artery bypass grafting. Whole blood platelet aggregation triggered by arachidonic acid was investigated using the Multiplate platelet function analyzer. Eleven of 23 patients with aspirin intake within the 5 days before the intervention showed an abnormal aggregation response. Nine of 77 patients who reported no aspirin intake before surgery had an abnormal aggregation response. There were no significant differences in chest tube drainage and red blood cell transfusion over the first 24 h postoperatively between patients with and without reported aspirin intake. There was no significant difference in chest tube drainage over the first 24 h postoperatively between patients showing normal or abnormal aggregation response. Patients with abnormal aggregation before intervention (<51 U) received significantly more platelet transfusion than patients with normal aggregation (1.1 U compared to 0.3 U, P = 0.001). Our results suggest that arachidonic acid-induced aggregation in whole blood may be a better predictor of platelet-related coagulopathy and platelet transfusion than the assessment of aspirin intake by patient self-reporting.